Maxwell Biosciences

Maxwell Biosciences is a preclinical-stage drug platform company focused on developing innovative therapeutics through its proprietary CLAROMER biotechnology platform. This technology generates low-molecular-weight compounds that mimic peptides, offering a distinct advantage over traditional macromolecules by facilitating easier membrane penetration. The company aims to create biomimetic therapeutics and synthetic compounds that effectively target and destroy viruses, bacteria, fungi, and certain cancers while preserving healthy cells. By imitating essential components of the immune system, Maxwell Biosciences enables healthcare professionals to address conditions that were previously deemed untreatable, positioning itself as a pioneer in the field of advanced therapeutics.